Our study supports that in vivo markers of neuronal density/function decrease and gliosis, which are histopathological features of AD, correlate with cognitive impairment, following spatial patterns seen in tau distribution and hypometabolism. The gene discussed is MAPT; the disease is Alzheimer disease.